Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Span Diagnostics Ltd Announces Intimation Of Sell Of Investment In Subsidiary Company


Tuesday, 28 May 2013 03:10am EDT 

Span Diagnostics Ltd announced that the Company has sold its entire shareholding held in Subsidiary Company namely M/s. Span Biotherapeutics Private Limited and accordingly the relation of holding Company and subsidiary Company between Span Diagnostics Limited and Span Biotherapeutics Private Limited has ceased with effect from May 27, 2013. 

Company Quote

50.65
0.05 +0.10%
26 Dec 2014